C-Type Natriuretic Peptide
- 15 March 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 93 (6), 1155-1159
- https://doi.org/10.1161/01.cir.93.6.1155
Abstract
Background Atrial and B-type natriuretic peptide are both known to be antagonists of the renin-angiotensin system. C-type natriuretic peptide (CNP) is a new member of this family except that its principal source is the vascular endothelium. This study tested the hypothesis that CNP is a local inhibitor of vascular angiotensin-converting enzyme (ACE) activity. Methods and Results Vascular ACE activity was assessed by the differential vascular response to angiotensin I and angiotensin II. Healthy male volunteers were studied with the use of brachial artery infusions of angiotensin I and angiotensin II at two doses, with and without coinfusion of CNP at 500 pmol/min (n=8) and hydralazine at 10 μg/min (n=8) (as a nonspecific vasodilator control). CNP alone and hydralazine alone caused similar increases in forearm blood flow (CNP+, 93.0±14.8%; hydralazine+, 84.2±22.6%). CNP inhibited the vasoconstrictive effect of angiotensin I (reduction in overall effect with CNP, 56.8±12.9%; P <.001) but not that of angiotensin II. Hydralazine did not significantly inhibit the effect of either angiotensin I or angiotensin II. Conclusions This evidence of a differential effect of CNP on the vascular response to angiotensin I but not to angiotensin II suggests that CNP acts as a local endogenous regulator of vascular ACE activity in the human forearm resistance vessels.Keywords
This publication has 16 references indexed in Scilit:
- Magnetic resonace imaging of heterotaxia in infantsJournal of the American College of Cardiology, 1994
- Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system".JCI Insight, 1992
- Effect of atrial natriuretic factor on angiotensin converting enzymeJournal Of Hypertension, 1990
- C-Type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brainBiochemical and Biophysical Research Communications, 1990
- The use of baselines in clinical trials of bronchodilatorsStatistics in Medicine, 1989
- Angiotensin II activates Na+-H+ exchange and stimulates growth in cultured vascular smooth muscle cellsJournal Of Hypertension, 1988
- Effects of incremental infusions of atrial natriuretic factor on aldosterone, renin, and blood pressure in humans.Hypertension, 1988
- Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process.Proceedings of the National Academy of Sciences, 1986
- True versus immunoreactive angiotensin II in human plasma.Hypertension, 1985
- A continuous spectrophotometric assay for angiotensin converting enzymeAnalytical Biochemistry, 1979